Advertisement
CNMD vs IART
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNMD is a Hold and IART is a Hold.
CNMD in -4.03% downward trend, declining for three consecutive days on November 06, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CNMD declined for three days, in 251 of 315 cases, the price declined further within the following month. The odds of a continued downward trend are 80%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for CNMD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In 12 of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at 67%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
CNMD broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CNMD entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on CNMD as a result. In 55 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for CNMD just turned positive on November 04, 2026. Looking at past instances where CNMD's MACD turned positive, the stock continued to rise in 35 of 47 cases over the following month. The odds of a continued upward trend are 74%.
CNMD moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CNMD crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +15.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNMD advanced for three days, in 200 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. CNMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.481) is normal, around the industry mean (4.142). P/E Ratio (27.838) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (11.253). Dividend Yield (0.016) settles around the average of (0.011) among similar stocks. P/S Ratio (1.055) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
IART in upward trend: price rose above 50-day moving average on November 10, 2026
IART moved above its 50-day moving average on November 10, 2026 date and that indicates a change from a downward trend to an upward trend. In 30 of 47 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 64%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IART's RSI Oscillator exited the oversold zone, 23 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 57%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on IART as a result. In 59 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for IART just turned positive on October 29, 2026. Looking at past instances where IART's MACD turned positive, the stock continued to rise in 25 of 43 cases over the following month. The odds of a continued upward trend are 58%.
Following a +8.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IART advanced for three days, in 182 of 292 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 56 cases where IART's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IART declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
IART broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IART entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.000) is normal, around the industry mean (4.142). IART has a moderately low P/E Ratio (-149.111) as compared to the industry average of (3.291). Projected Growth (PEG Ratio) (0.669) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.751) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. IART’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IART’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
CNMD | IART | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 66 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 62 Fair valued | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 81 | 91 | |
PRICE GROWTH RATING 1..100 | 39 | 54 | |
P/E GROWTH RATING 1..100 | 15 | 15 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IART's Valuation (4) in the Medical Specialties industry is somewhat better than the same rating for CNMD (62). This means that IART’s stock grew somewhat faster than CNMD’s over the last 12 months.
IART's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as CNMD (100). This means that IART’s stock grew similarly to CNMD’s over the last 12 months.
CNMD's SMR Rating (81) in the Medical Specialties industry is in the same range as IART (91). This means that CNMD’s stock grew similarly to IART’s over the last 12 months.
CNMD's Price Growth Rating (39) in the Medical Specialties industry is in the same range as IART (54). This means that CNMD’s stock grew similarly to IART’s over the last 12 months.
CNMD's P/E Growth Rating (15) in the Medical Specialties industry is in the same range as IART (15). This means that CNMD’s stock grew similarly to IART’s over the last 12 months.
| CNMD | IART | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 67% | 2 days ago 57% |
| Stochastic ODDS (%) | 2 days ago 77% | 2 days ago 73% |
| Momentum ODDS (%) | 2 days ago 63% | 2 days ago 62% |
| MACD ODDS (%) | 2 days ago 74% | 2 days ago 58% |
| TrendWeek ODDS (%) | 2 days ago 66% | 2 days ago 65% |
| TrendMonth ODDS (%) | 2 days ago 63% | 2 days ago 62% |
| Advances ODDS (%) | 8 days ago 68% | 2 days ago 62% |
| Declines ODDS (%) | 6 days ago 80% | 6 days ago 78% |
| BollingerBands ODDS (%) | 2 days ago 77% | 2 days ago 73% |
| Aroon ODDS (%) | 2 days ago 72% | 2 days ago 73% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNMD’s FA Score shows that 1 FA rating(s) are green while IART’s FA Score has 2 green FA rating(s).
- CNMD’s FA Score: 1 green, 4 red.
- IART’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNMD’s TA Score shows that 5 TA indicator(s) are bullish while IART’s TA Score has 5 bullish TA indicator(s).
- CNMD’s TA Score: 5 bullish, 5 bearish.
- IART’s TA Score: 5 bullish, 4 bearish.
Price Growth
CNMD (@Medical/Nursing Services) experienced а +8.43% price change this week, while IART (@Medical/Nursing Services) price change was +6.60% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
Reported Earning Dates
CNMD is expected to report earnings on Feb 03, 2027.
IART is expected to report earnings on Mar 03, 2027.
Industries' Descriptions
@Medical/Nursing Services (-2.89% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
CNMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNMD has been loosely correlated with NVST. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CNMD jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To CNMD | 1D Price Change % | ||
|---|---|---|---|---|
| CNMD | 100% | -1.41% | ||
| NVST - CNMD | 49% Loosely correlated | -0.50% | ||
| KIDS - CNMD | 49% Loosely correlated | -1.50% | ||
| IART - CNMD | 48% Loosely correlated | +1.11% | ||
| ENOV - CNMD | 47% Loosely correlated | -1.12% | ||
| ZBH - CNMD | 46% Loosely correlated | -0.93% | ||
More | ||||
IART and
Correlation & Price change
A.I.dvisor indicates that over the last year, IART has been loosely correlated with RVTY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then RVTY could also see price increases.
| Ticker / NAME | Correlation To IART | 1D Price Change % | ||
|---|---|---|---|---|
| IART | 100% | +1.11% | ||
| RVTY - IART | 49% Loosely correlated | -1.01% | ||
| CNMD - IART | 48% Loosely correlated | -1.41% | ||
| MTD - IART | 44% Loosely correlated | -0.62% | ||
| A - IART | 43% Loosely correlated | -1.27% | ||
| AZTA - IART | 43% Loosely correlated | -1.15% | ||
More | ||||